Contact

TSB sells its chronic care management subsidiary to multinational Air Liquide Healthcare


, ,
Integral service around a transaction
BY : Diego GutiérrezJanuary Tue, 2016

The introduction of new technologies in patient care services is a necessity for companies in the sector that want to be competitive. According to a study by Venture Watch Research for the first half of 2015, the e-health sector is the third leading sector in terms of investment in Spanish start-ups (8.8% of volume) behind financial technologies and tied with e-commerce (9.9% of volume each). This has led to companies in the healthcare sector deciding to take the plunge and bet on the purchase of companies technology such as the recent purchase of CHS by France's Air Liquide healthcare or Almirall's purchase of ThermiGen LLC.

health

Air Liquide Healthcare buys CHS

Air Liquide Healthcare bought in September 2015 CHS, a subsidiary of the Valencian company TSB, which specialises in the management of chronically ill patients.

Air Liquide Healthcare and TSB began discussions for the transfer of technology and know-how in mid-2014. The operation is structured in two phases: in the first phase, Air Liquide acquired 60% of CHS's capital; in the second phase, in 2018, the multinational will acquire the entire company.

CHS, develops software technology to improve and optimise the management of the coordinated continuum of care for people suffering from chronic diseases such as heart failure, chronic obstructive pulmonary disease (COPD), or diabetes.

Air Liquide Healthcare supplies medical gases to more than 7,500 hospitals and served more than 1.2 million home patients worldwide in 2014. The healthcare business of the gases company recorded revenues of €2.57 billion last year, 50% of which came from the home business.

For Air Liquide Healthcare, the transaction represents the incorporation of a strategic technological asset for the worldwide development of the chronic care management business. Air Liquide also strengthens its home care business in Spain, which is channelled through the subsidiaries Gasmedi and Vitalaire.

 

With this operation, TSB successfully completes a second case of technology transfer developed internally and validated in clinical studies and pilot trials, prior to its deployment in the market through investee companies or through the sale of the asset, as in this case. The first success story was the transfer of technology for locating people and assets in hospital environments through the subsidiary Mysphera, in 2012. Today, Mysphera is a leader in its sector in Spain with the largest installation in Europe at La Fe hospital in Valencia and installations in more than 10 hospitals in Spain and Chile. TSB continues to hold a majority stake in Mysphera.

 

Almirall acquires ThermiGen LLC

The Barcelona-based pharmaceutical company Almirall has exercised the option to purchase 100 % from ThermiGen LLC, a medical aesthetic technology company that leads the development and production of thermistor-regulated energy systems for plastic surgery and aesthetic dermatology applications.

ThermiGen's product portfolio is based on thermistor-regulated energy systems that are becoming known as the 'Science of Heat', allowing physicians to use temperature as a parameter to treat a variety of aesthetic soft tissue and nerve conditions.

ThermiRF®, the company's flagship product, is the first FDA-approved aesthetic medical device that employs radiofrequency-controlled temperature for use in dermatological and general surgical procedures for electrocoagulation and haemostasis and to create lesions in nerve tissue.

If you are looking for financing, please contact us. Abra-Invest has a team of experts in alternative financing at your disposal. Fill in the contact form or call us on + 34 946424142

Other posts that may interest you

Psious, TopDoctors, IglobalMed: Health 2.0 startups receive funding

Analysis of the Internet of Things for Health

H2020 Grants for the e-health sector 2016- 2017

The M&A Professionals

Meet our services

CONTACT US

MEET
OUR
METODOLOGY

Do you want to be up to date?

SUSCRIBE OUR NEWSLETTER

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu